Sabato 27 ottobre 2012 - Pacini Editore
Sabato 27 ottobre 2012 - Pacini Editore
Sabato 27 ottobre 2012 - Pacini Editore
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
400<br />
Fig. 4. HER-2/neu, score 3+, Cdi (40x).<br />
Fig. 5. C-erbB2 gene amplification.<br />
Results. There was no statistical significance for HR expression<br />
(Figg. 1-2) in two subsets (pT1ab VS pT1c, χ 2 p:0.897). A high<br />
proliferative activity (Fig. 3) was detected in 75.7% and 24.3%<br />
respectively for pT1c and pT1a-b (τ-test, p:0.002). HER2/Neu<br />
was positive (IHC, FISH, Figg. 4-5) in 22/187 (11.8%) cases<br />
of pT1c and in 9/105 (8.5%) cases of pT1a-b; the proliferative<br />
activity index was high in both HER2/Neu + subset (τ-test,<br />
p:0.985). Follow up data (mean FU: 56.3 months; range 9-108<br />
months) were available in 22/31 patients HER2/Neu + (8<br />
pT1a-b, 14 pT1c). Two relapses (9.1%) 4 were observed: the<br />
first (pT1b, G3, high Ki-67 treated only with radio-therapy),<br />
recurred both locally and on visceral sites; the second patient<br />
(pT1c, G2, high Ki-67 treated only with hormonal therapy)<br />
showed a triple negative biological features on a re-biopsy performed<br />
on liver metastases.<br />
Conclusion. We observed that different Ki-67 expression 5 , in<br />
two subset (pT1a-b vs pT1c), is associated with tumor size and<br />
this difference is lost in HER2/Neu positive cases regardless of<br />
tumor size (τ-test, p:0.985). We concluded that HER2/neu overexpression/amplification,<br />
could represent a significant marker<br />
of high risk of relapse and could be a prognostic and predictive<br />
factor also in pT1N0M0 breast cancer 6 .<br />
references<br />
1 Neville AM, et al. J Clin Oncol;10:696-705.<br />
2 Sánchez-Muñoz A et al. Breast Journal;17:32-8.<br />
3 Wolff AC, et al. Arch Pathol Lab Med 2007;131:18-43.<br />
4 Joensuu H, et al. Clin Cancer Res 2003;9:923-30.<br />
5 Colleoni M, et al. Annals of Oncology;15:1633-9.<br />
6 Curigliano G, et al. J Clin Oncol 2009;<strong>27</strong>:5693-9.<br />
CONGRESSO aNNualE di aNatOmia patOlOGiCa SiapEC – iap • fiRENzE, 25-<strong>27</strong> OttOBRE <strong>2012</strong><br />
OSSO E PArTI MOLLI<br />
Angiomyomatous hamartoma of the left inguinocrural<br />
area: a case report<br />
M.P. Brisigotti1 , F. Sarocchi1 , P. Calamaro1 , M. Bruzzone1 ,<br />
F. Spagnolo3 , F. Cafiero4 , M. Trapasso3 , L. Moresco4 , B. Spina2 1 University of Genoa, Histhopathology, DISC, Azienda Ospedaliera e<br />
Universitaria San Martino-IRCCS-IST, Genoa; 2 National Institute of<br />
Cancer Research (IST), Pathology Unit, Azienda Ospedaliera e Universitaria<br />
San Martino-IRCCS-IST, Genoa; 3 National Institute of Cancer Research<br />
(IST), Plastic Surgery Unit, Azienda Ospedaliera ed Universitaria<br />
San Martino-IRCCS-IST, Genoa; 4 National Institute of Cancer Research<br />
(IST), Surgical Oncology Unit, Azienda Ospedaliera ed Universitaria San<br />
Martino-IRCCS-IST, Genoa<br />
Introduction. Angiomyomatous hamartoma (AMH) of the<br />
lymph node is a benign vascular disorder and has been described<br />
as a primary vascular tumor characterized by the replacement of<br />
lymph node tissue by blood vessels, smooth muscle and fibrous<br />
tissue in a sclerotic lymphatic stroma. These tumors of unknown<br />
etiology, first described by Chan et al in 1992, are rare disease<br />
and they usually involve inguinal and femoral lymph nodes.<br />
Materials and methods. The patient is a 29 year old woman with<br />
left inguino crural poli-adenopathy and a single painfull mass,<br />
deep in the layers above the femoral nerve and vessels, developed<br />
over the last three months. Color Doppler Ultrasound and MRI<br />
revealed a solid mass measuring 2,5 cm with low vascular supply<br />
and regular margins. A pre-operative lymphoscintigraphy showed<br />
abnormalities in the lymph node flow in the inguino-crural and<br />
pelvic lymph nodes. The mass was clinically diagnosed as a<br />
schwannoma. Since the tumor gradually enlarged, wide excision<br />
of the mass was performed.<br />
Results. The gross specimen was composed of fibro-adipose tissue<br />
measuring 8 x 4 x 2 cm in the contest of which there was a<br />
nodular single mass measuring 2 cm that, on cut section had a firm,<br />
gray-white appearance (Fig. 1). The specimen was extensively<br />
sampled for histologic examination. Microscopically on routine<br />
hematoxylin and eosin stains the nodular mass was a lymph node<br />
with a peripheral rim of normal lymphoid tissue, with few residual<br />
follicles, which was almost completely replaced by a proliferation<br />
of numerous thick-walled muscular blood vessels (Fig. 2). This<br />
proliferation was associated with haphazardly arranged bundles of<br />
smooth muscle cells within a sclerotic stroma. There were also few<br />
compressed lobules of benign adipocytes. None of the constituent<br />
cells displayed cytologic atypia. Mitoses and necrosis were absent.<br />
On immunohistochemical stains there was a strong reactivity for<br />
smooth muscle actin (SMA) (Fig. 3) and desmin (Fig. 4) in the<br />
spindle shaped cells dispersed throughout the fibrous tissue confirming<br />
the muscular origine of these elements.<br />
Morphological and immunohistochemical results lead to a diagnosis<br />
of an angiomyomatous hamartoma.<br />
Fig. 1.